Rivaroxaban for the treatment of cerebral venous thrombosis

New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There ...

https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-021-02091-1

Source: BMC Neurology - February 15, 2021 Category: Neurology Authors: Sara Esmaeili, Meysam Abolmaali, Sobhan Aarabi, Mohammad Reza Motamed, Samira Chaibakhsh, Mohammad Taghi Joghataei, Mohammad Mojtahed and Zahra Mirzaasgari Tags: Research article Source Type: research